| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kiyotaka Nemoto, Hiromasa Sakaguchi, Wataru Kasai, Masatoshi Hotta, Ryotaro Kamei, Tomoyuki Noguchi, Ryogo Minamimoto, Tetsuaki Arai, Takashi Asad. Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRI. Journal of neuroimaging : official journal of the American Society of Neuroimaging. vol 31. issue 3. 2021-07-14. PMID:33476487. |
dementia with lewy bodies (dlb) is the second most prevalent cause of degenerative dementia next to alzheimer's disease (ad). |
2021-07-14 |
2023-08-13 |
Not clear |
| Giovanni Zorzi, Michel Thiebaut de Schotten, Renzo Manara, Cinzia Bussè, Maurizio Corbetta, Annachiara Cagni. White matter abnormalities of right hemisphere attention networks contribute to visual hallucinations in dementia with Lewy bodies. Cortex; a journal devoted to the study of the nervous system and behavior. vol 139. 2021-07-12. PMID:33848693. |
functional alterations of the visual attention networks in a setting of impaired visual information processing have a role in the genesis of visual hallucinations (vh) in dementia with lewy bodies (dlb). |
2021-07-12 |
2023-08-13 |
Not clear |
| Jakub Antczak, Gabriela Rusin, Agnieszka Słowi. Transcranial Magnetic Stimulation as a Diagnostic and Therapeutic Tool in Various Types of Dementia. Journal of clinical medicine. vol 10. issue 13. 2021-07-11. PMID:34203558. |
dementia with lewy bodies (dlb) is associated with sai decrease. |
2021-07-11 |
2023-08-13 |
Not clear |
| Jakub Antczak, Gabriela Rusin, Agnieszka Słowi. Transcranial Magnetic Stimulation as a Diagnostic and Therapeutic Tool in Various Types of Dementia. Journal of clinical medicine. vol 10. issue 13. 2021-07-11. PMID:34203558. |
dlb and other dementia types are also characterized by impairment of short interval intracortical inhibition. |
2021-07-11 |
2023-08-13 |
Not clear |
| Jara M Baena-Montes, Sahar Avazzadeh, Leo R Quinla. α-synuclein pathogenesis in hiPSC models of Parkinson's disease. Neuronal signaling. vol 5. issue 2. 2021-07-10. PMID:34239711. |
α-synuclein is implicated in many disease states including dementia with lewy bodies (dlb) and alzheimer's disease. |
2021-07-10 |
2023-08-13 |
Not clear |
| Niels Hansen, Claudia Lange, Charles Timäus, Jens Wiltfang, Caroline Boute. Assessing Nigrostriatal Dopaminergic Pathways Frontiers in aging neuroscience. vol 13. 2021-07-09. PMID:34234666. |
assessing nigrostriatal dopaminergic pathways (123)-i-2-ß-carbomethoxy-3ß-(4-iodophenyl)-n-(3-fluoropropyl) nortro- pane single photon emission computed tomography (123i-fp-cit spect) was validated to distinguish alzheimer's dementia from dementia with lewy bodies (dlb) by european medical agencies. |
2021-07-09 |
2023-08-13 |
Not clear |
| Melanie P Jensen, Olivera Spasic-Boskovic, James B Rowe, Clare Galton, Kieren S J Allinso. Clinicopathological co-occurrence of Fahr's disease and dementia with Lewy bodies. Clinical neuropathology. vol 39. issue 5. 2021-07-09. PMID:32145757. |
we present the clinicopathological findings of a case of combined fahr's disease (fd) and dementia with lewy bodies (dlb), associated with a novel pathogenic mutation. |
2021-07-09 |
2023-08-13 |
Not clear |
| Victor Calil, Andrea Silveira de Souza, Felipe Kenji Sudo, Gustavo Santiago-Bravo, Naima Assunção, Claudia Drummond, Fernanda Rodrigues, Rejane Soares, Natalia Oliveira, Alina Teldeschi, Gabriel Bernardes, Gabriel Lima, Camila Lima, Marco Antonio Lima, Paulo Matto. Anosognosia for memory in dementia with Lewy bodies compared with Alzheimer's disease. International journal of geriatric psychiatry. vol 36. issue 7. 2021-07-08. PMID:33594752. |
although dementia with lewy bodies (dlb) is the second most common degenerative dementia, there is little evidence of memory deficit awareness in this condition. |
2021-07-08 |
2023-08-13 |
Not clear |
| Victor Calil, Andrea Silveira de Souza, Felipe Kenji Sudo, Gustavo Santiago-Bravo, Naima Assunção, Claudia Drummond, Fernanda Rodrigues, Rejane Soares, Natalia Oliveira, Alina Teldeschi, Gabriel Bernardes, Gabriel Lima, Camila Lima, Marco Antonio Lima, Paulo Matto. Anosognosia for memory in dementia with Lewy bodies compared with Alzheimer's disease. International journal of geriatric psychiatry. vol 36. issue 7. 2021-07-08. PMID:33594752. |
the objectives of this research were to compare anosognosia between individuals with dlb and dementia due to alzheimer's disease (ad) and to evaluate whether medial temporal atrophy, a marker of ad pathology, could help to explain different rates of anosognosia in dlb and dementia due to ad. |
2021-07-08 |
2023-08-13 |
Not clear |
| Yusuke Saito, Keisuke Noto, Ryota Kobayashi, Akihito Suzuki, Daichi Morioka, Hiroshi Hayashi, Koichi Otan. Catatonia as the Initial Manifestation of Dementia with Lewy Bodies. The American journal of case reports. vol 22. 2021-07-08. PMID:34230446. |
so far, although 1 case of dementia with lewy bodies (dlb) with catatonia has been reported, there have been no reports on patients with dlb whose initial symptom was a catatonia. |
2021-07-08 |
2023-08-13 |
Not clear |
| Paulo Bugalho, Marta Magriço, Luísa Alves, Cláudia Borbinh. Objective sleep data as predictors of cognitive decline in dementia with Lewy Bodies and Parkinson's disease. Sleep medicine. vol 80. 2021-07-05. PMID:33610074. |
parkinson's disease (pd) and dementia with lewy bodies (dlb) prognosis depends on cognitive function evolution. |
2021-07-05 |
2023-08-13 |
Not clear |
| Ambra Stefani, Joan Santamaria, Alex Iranzo, Heinz Hackner, Carlos H Schenck, Birgit Hög. Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson's disease dementia. Sleep medicine. vol 81. 2021-07-05. PMID:33714847. |
rapid eye movement sleep behavior disorder (rbd) is frequent in dementia with lewy bodies (dlb) and parkinson's disease dementia (pdd), and poses a risk of injury to patients and their bed partners. |
2021-07-05 |
2023-08-13 |
Not clear |
| Lindsay E Stoyka, Casey L Mahoney, Drake R Thrasher, Drèson L Russell, Anna K Cook, Anner T Harris, Ashwin Narayanan, Tiara P Janado, David G Standaert, Erik D Roberson, Laura A Volpicelli-Dale. Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau. eNeuro. vol 8. issue 3. 2021-07-02. PMID:33972291. |
synucleinopathies including parkinson's disease (pd) and dementia with lewy bodies (dlb) are characterized by neuronal intracellular inclusions of α-synuclein. |
2021-07-02 |
2023-08-13 |
mouse |
| Lindsay E Stoyka, Casey L Mahoney, Drake R Thrasher, Drèson L Russell, Anna K Cook, Anner T Harris, Ashwin Narayanan, Tiara P Janado, David G Standaert, Erik D Roberson, Laura A Volpicelli-Dale. Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau. eNeuro. vol 8. issue 3. 2021-07-02. PMID:33972291. |
pd dementia (pdd) and dlb are collectively the second most common cause of neurodegenerative dementia. |
2021-07-02 |
2023-08-13 |
mouse |
| Alison Killen, Darren Flynn, Nicola O'Brien, John-Paul Taylo. The feasibility and acceptability of a psychosocial intervention to support people with dementia with Lewy bodies and family care partners. Dementia (London, England). 2021-07-02. PMID:34171967. |
psychosocial support for people with dementia with lewy bodies (dlb) and family care partners is frequently lacking, despite the need expressed by those with lived experience. |
2021-07-02 |
2023-08-13 |
Not clear |
| Inger van Steenoven, Marleen J A Koel-Simmelink, Leonie J M Vergouw, Betty M Tijms, Sander R Piersma, Thang V Pham, Claire Bridel, Gian-Luca Ferri, Cristina Cocco, Barbara Noli, Paul F Worley, Mei-Fang Xiao, Desheng Xu, Patrick Oeckl, Markus Otto, Wiesje M van der Flier, Frank Jan de Jong, Connie R Jimenez, Afina W Lemstra, Charlotte E Teunisse. Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach. Molecular neurodegeneration. vol 15. issue 1. 2021-07-01. PMID:32552841. |
diagnosis of dementia with lewy bodies (dlb) is challenging, largely due to a lack of diagnostic tools. |
2021-07-01 |
2023-08-13 |
Not clear |
| Frederick M Lang, Daniel Y Kwon, Dag Aarsland, Brad Boeve, Babak Tousi, Mark Harnett, Yi Mo, Marwan Noel Sabbag. An international, randomized, placebo-controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY-DLB). Alzheimer's & dementia (New York, N. Y.). vol 7. issue 1. 2021-07-01. PMID:34189249. |
a phase 2b clinical trial, headway-dlb, was performed to assess treatment with intepirdine, a serotonin receptor antagonist, in patients with dementia with lewy bodies (dlb). |
2021-07-01 |
2023-08-13 |
Not clear |
| Victor Calil, Felipe Kenji Sudo, Gustavo Santiago-Bravo, Marco Antonio Lima, Paulo Matto. Anosognosia in dementia with Lewy bodies: a systematic review. Arquivos de neuro-psiquiatria. vol 79. issue 4. 2021-06-29. PMID:34133514. |
although dementia with lewy bodies (dlb) is the second most common form of degenerative dementia, literature on anosognosia in this disease is scarce. |
2021-06-29 |
2023-08-13 |
Not clear |
| Carla Abdelnour, Daniel Ferreira, Ketil Oppedal, Lena Cavallin, Olivier Bousiges, Lars Olof Wahlund, Jakub Hort, Zuzana Nedelska, Alessandro Padovani, Andrea Pilotto, Laura Bonanni, Milica G Kramberger, Mercè Boada, Eric Westman, Javier Pagonabarraga, Jaime Kulisevsky, Frédéric Blanc, Dag Aarslan. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies. NeuroImage. Clinical. vol 27. 2021-06-25. PMID:32674011. |
alzheimer's disease (ad)-related pathology is frequently found in patients with dementia with lewy bodies (dlb). |
2021-06-25 |
2023-08-13 |
Not clear |
| E E Wolters, M van de Beek, R Ossenkoppele, S S V Golla, S C J Verfaillie, E M Coomans, T Timmers, D Visser, H Tuncel, F Barkhof, R Boellaard, A D Windhorst, W M van der Flier, Ph Scheltens, A W Lemstra, B N M van Bercke. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study. NeuroImage. Clinical. vol 28. 2021-06-25. PMID:33395993. |
alpha-synuclein often co-occurs with alzheimer's disease (ad) pathology in dementia with lewy bodies (dlb). |
2021-06-25 |
2023-08-13 |
Not clear |